Assessing Arcutis Biotherapeutics After 99% YTD Surge and Mixed Valuation Signals
If you are wondering whether Arcutis Biotherapeutics is still worth a closer look after its big run up,…
Challenges and opportunities in delivering gene therapies for sickle cell disease and beta thalassemia
The first study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia…
New microfluidic-based biosensing platform helps track live antibody secretion dynamics
A research team at the Terasaki Institute, led by Dr. Vadim Jucaud in collaboration with Dr. Jing Yong…